» Articles » PMID: 22086260

Time to Rethink: an Evidence-based Response from Pelvic Surgeons to the FDA Safety Communication: "UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse"

Overview
Publisher Springer
Date 2011 Nov 17
PMID 22086260
Citations 134
Authors
Affiliations
Soon will be listed here.
Abstract

In July of 2011 the U.S. Food and Drug Administration (FDA) released a safety communication entitled "UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse." The stated purpose of this communication is to inform health care providers and patients that serious complications with placement of this mesh are not rare and that it is not clear that these repairs are more effective than nonmesh repair. The comments regarding efficacy are based on a systematic review of the scientific literature from 1996-2011 conducted by the FDA. Our review of the literature during this time yields some different conclusions regarding the safety and efficacy of mesh use in prolapse repair. It may be useful to consider this information prior to making recommendations regarding mesh use in prolapse surgery according to the recent UPDATE.

Citing Articles

Feasibility and safety of biologic OviTex mesh in ventral mesh rectopexy: a prospective pilot study.

Boom M, van der Schans E, Wijffels N, Verheijen P, Consten E Tech Coloproctol. 2025; 29(1):65.

PMID: 39948225 PMC: 11825524. DOI: 10.1007/s10151-024-03097-w.


Mesh-associated pain syndrome: predictors for continence and prolapse mesh removal surgery in a single centre.

Elneil S, Delanerolle G, Zeng Y, Chunli D, Shetty A, Shi J BMC Womens Health. 2024; 24(1):585.

PMID: 39487432 PMC: 11529248. DOI: 10.1186/s12905-024-03393-5.


Quantifying the effects of five rehabilitation training methods on the ability of elderly men to control bowel movements: a finite element analysis study.

Wang R, Liu G, Jing L, Zhang J, Ye Y, Zhu H Front Bioeng Biotechnol. 2024; 12:1392448.

PMID: 38988865 PMC: 11233532. DOI: 10.3389/fbioe.2024.1392448.


Acellular Dermal Matrices as an New Alternative for Treatment in Reproductive Organ Static Disorders: A Pilot Study.

Sadlocha M, Skowronek K, Labus W, Staniczek J, Mansar-Dyrbus M, Stojko R J Clin Med. 2024; 13(6).

PMID: 38541776 PMC: 10970872. DOI: 10.3390/jcm13061550.


Puerarin-Loaded Electrospun Patches with Anti-Inflammatory and Pro-Collagen Synthesis Properties for Pelvic Floor Reconstruction.

Zhang D, Xu D, Huang X, Wei Y, Tang F, Qin X Adv Sci (Weinh). 2024; 11(21):e2308590.

PMID: 38509840 PMC: 11151014. DOI: 10.1002/advs.202308590.


References
1.
Abed H, Rahn D, Lowenstein L, Balk E, Clemons J, Rogers R . Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review. Int Urogynecol J. 2011; 22(7):789-98. DOI: 10.1007/s00192-011-1384-5. View

2.
Benson J, Lucente V, McClellan E . Vaginal versus abdominal reconstructive surgery for the treatment of pelvic support defects: a prospective randomized study with long-term outcome evaluation. Am J Obstet Gynecol. 1996; 175(6):1418-21; discussion 1421-2. DOI: 10.1016/s0002-9378(96)70084-4. View

3.
Olsen A, Smith V, Bergstrom J, Colling J, Clark A . Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997; 89(4):501-6. DOI: 10.1016/S0029-7844(97)00058-6. View

4.
Nguyen J, Burchette R . Outcome after anterior vaginal prolapse repair: a randomized controlled trial. Obstet Gynecol. 2008; 111(4):891-8. DOI: 10.1097/AOG.0b013e31816a2489. View

5.
Iglesia C, Sokol A, Sokol E, Kudish B, Gutman R, Peterson J . Vaginal mesh for prolapse: a randomized controlled trial. Obstet Gynecol. 2010; 116(2 Pt 1):293-303. DOI: 10.1097/AOG.0b013e3181e7d7f8. View